What does this research mean for the field?

The putative cannabinoid receptor GPR55 regulates bone mass by suppressing osteoclast formation while stimulating osteoclast function, and its antagonism by cannabidiol (CBD) reduces bone resorption in vivo. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

September 3, 2009Proceedings of the National Academy of SciencesOpen Access

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

View Full Paper

Ask AI

Bookmark

Authors

LWLauren S. Whyte ERErik Ryberg NSNatalie A. Sims

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Whyte et al. (2009) studied this question.

synapsesocial.com/papers/6aaa63c0346271c31733b802 https://doi.org/10.1073/pnas.0902743106

View Full Paper

Ask AI

Bookmark

September 3, 2009Proceedings of the National Academy of SciencesOpen Access

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

View Full Paper

Ask AI

Bookmark

Authors

LWLauren S. Whyte ERErik Ryberg NSNatalie A. Sims

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Whyte et al. (2009) studied this question.

synapsesocial.com/papers/6aaa63c0346271c31733b802 https://doi.org/10.1073/pnas.0902743106

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark